Nuveen Asset Management, LLC Aclaris Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.92 - $1.44 $251,385 - $393,472	-273,245 Reduced 62.12%	166,656 $206,000
Q4 2023 Feb 14, 2024	SELL	$0.64 - $6.49 $13,063 - $132,473	-20,412 Reduced 4.43%	439,901 $461,000
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $1.7 Million - $2.83 Million	258,896 Added 128.54%	460,313 $3.15 Million
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $95,910 - $129,339	12,156 Added 6.42%	201,417 $2.09 Million
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $87,215 - $221,431	-12,336 Reduced 6.12%	189,261 $1.53 Million
Q4 2022 Feb 14, 2023	SELL	$14.33 - $18.37 $284,120 - $364,221	-19,827 Reduced 8.95%	201,597 $3.18 Million
Q3 2022 Nov 14, 2022	SELL	$13.07 - $18.22 $382,820 - $533,663	-29,290 Reduced 11.68%	221,424 $3.49 Million
Q2 2022 Aug 15, 2022	SELL	$10.16 - $17.08 $678,952 - $1.14 Million	-66,826 Reduced 21.04%	250,714 $3.5 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.92 $149,840 - $275,681	15,384 Added 5.09%	317,540 $5.12 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $368,909 - $555,920	30,066 Added 11.05%	302,156 $4.39 Million
Q3 2021 Nov 12, 2021	BUY	$13.38 - $18.8 $1.18 Million - $1.66 Million	88,303 Added 48.05%	272,090 $4.94 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $3.14 Million - $5.44 Million	183,787 New	183,787 $3.23 Million
Q2 2020 Aug 14, 2020	SELL	$1.04 - $1.73 $114,400 - $190,300	-110,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$0.75 - $2.18 $6,636 - $19,290	8,849 Added 8.75%	110,000 $114,000
Q4 2019 Feb 14, 2020	SELL	$1.02 - $1.97 $14,572 - $28,145	-14,287 Reduced 12.38%	101,151 $191,000
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $9,892 - $30,929	-12,522 Reduced 9.79%	115,438 $125,000
Q2 2019 Aug 15, 2019	BUY	$2.13 - $7.06 $272,554 - $903,397	127,960 New	127,960 $280,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$41.3 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$13.6 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$9.78 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$8.72 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$7.99 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account